Healthcare Services company Inventurus Knowledge Solutions announced Q1FY26 results Revenue at Rs 7,401 million (15.6% YoY / + 2.2% QoQ growth). EBITDA at Rs 2,378 million at 32.1% of revenue (36.3% YoY / +5.1% QoQ growth). PAT at Rs 1,515 million at 20.5% of revenue (58.7% YoY / 2.5% QoQ growth) Adjusted PAT at Rs 1,682 million at 22.7% of revenue (51.4% YoY / 2.2% QoQ growth). Sachin K. Gupta, Founder & Global CEO, IKS Health, said: “Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution.” “The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities. As we move forward, our focus remains on deepening client value, investing in innovation, and scaling our platform to address the evolving needs of the healthcare ecosystem.” Nithya Balasubramanian, CFO, IKS Health said: “We delivered a strong financial performance in Q1FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation.” Result PDF
Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Inventurus Knowledge Solutions announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue growth in Q4, 17% YoY in INR, 13% YoY in USD Q4 EBITDA up 68% YoY; 13% QoQ PAT up 133% growth YoY; 14% QoQ Adjusted PAT up 108% YoY; 13% QoQ Revenue: 7,240 million PAT: Rs 1,478 million EBITDA: Rs 2,262 million Adjusted PAT: Rs 1,646 million FY25 Financial Highlights: Revenue at Rs 26,640 million (47% YoY) EBITDA at Rs 7,911 million (50% YoY) PAT at Rs 4,861 million (31% YoY) Adjusted PAT at Rs 5,504 (39% YoY) Sachin K. Gupta, Founder & CEO, IKS Health. said, “The results for the quarter reflect the strength of our business where we have delivered industry leading revenue growth owing to ramp up of new clients and continuous margin improvement as we continue to transform the business using technology and global human capital. Our Q4FY25 EBITDA margins have crossed 31%, a significant improvement from the 24% proforma margin of FY24,” “The last quarter saw five prominent client wins including three platform deals which gives us the confidence in our strategy of building the full breadth of our platform in a market that largely consists of point solutions companies.” Nithya Balasubramanian, CFO, IKS Health said, “We have delivered a very healthy margin and strong revenue growth of 17% YoY and 10% QoQ despite some compression in revenue as we focus on the right set of customers and globalize the legacy AQuity workforce. Ongoing investments in technology and AI will remain central to our strategy for achieving excellence in outcomes and client satisfaction.” Result PDF
Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.